Abstract:Objective: More and more studies have demonstrated that the p53 tumor suppressor gene plays an important role in controlling tumor angiogenesis. There is some evidence that p53 mutations cause overexpression of vascular endothelial growth factor (VEGF), a major inducer of angiogenesis. In addition, there is now growing evidence that several malignancies express receptors for VEGF, especially receptor-2 (Flk-1/KDR), raising the possibility that the VEGF/VEGF receptor axis may serve as an autocrine pathway in some tumors. We examined the expression of p53 and VEGF and its receptor FlK-1, together with microvessel count (MVC) to investigate the role of VEGF as an angiogenic marker, the presence of VEGF/Flk-1 axis, and the possible role of p53 in the regulation of angiogenesis in human gallbladder carcinoma. Methods: Surgically resected specimens of 49 gallbladder carcinomas were studied by immunohistochemical staining for p53 protein, VEGF, Flk-1 and factor VIII-related antigen. VEGF expression and mutant p53 expression were then correlated with Nevin stage, differentiation grade, MVC, and lymph nodes metastasis. Results: VEGF, Flk-1 expression and positive p53 protein accumulation and BEGF expression was found in 63.3%, 67.3% and 61.2% of tumors, respectively. The expression of Flk-1 was markedly correlated with VEGF (P<0.05). The percentage of the patients with both positive VEGF and Flk-1 expressions was 49.0% (24/49), and their MVC value was markedly higher than that of the others. P53 and VEGF staining status were identical in 55.1% of tumors. The Nevin staging of p53-or VEGF-positive tumors was significantly later than negative tumors. The MVC in p53-or VEGF-positive tumors was significantly higher than that in negative tumors, and MVC in both p53- and VEGF-negative tumors was significantly lower than that in the other subgroups. Conclusion: The findings suggest the VEGF/Flk-1 axis and p53-VEGF pathway tumor angiogenesis in human gallbladder carcinoma. Combined analysis of p53 and VEGF expression, plus Flk-1 and VEGF expression might be useful for predicting the tumor vacularity and biologic behaviors of gallbladder cancer.

Relationship Between Urokinase-Type Plasminogen Activator Receptor and Vascular Endothelial Growth Factor Expression and Metastasis of Gallbladder Cancer.

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expression and clinical significance of urokinase-type plasminogen activator an d its receptor in gastric cancer

Correlation of UPAR and VEGF expression with invasion and metastasis in human hepatocellular carcinoma

Relationship Between the expression of uPAR and Invasion and Metasitasis of Hepatocellular Carcinoma

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Detection of uPA and MVD in human colorectal carcinoma tissue

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Analysis of P53 and Vascular Endothelial Growth Factor and Its Receptor Flk-1 Expression in Human Gallbladder Carcinoma for Determination of Tumor Vascularity

Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

Prognostic Implications of Estrogen Receptor 1 and Vascular Endothelial Growth Factor A Expression in Primary Gallbladder Carcinoma.

The Correlation Between Expression of Vascular Endothelial Growth Factor and Invasiveness and Metastasis of Gastric Carcinoma

Expression of Urokinase-Type Plasminogen Activator (upa) and Vascular Endothelial Growth Factor (VEGF) in Esophageal Cancer and Their Influence to Tumor Angiogenesis

Urokinase-type Plasminogen Activator, Its Receptor and Inhibitor Expression in Hepatocellular Carcinoma Relation to Cancer Invasiveness and Prognosis

Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma

Association of P53, P16, and Vascular Endothelial Growth Factor Protein Expressions with the Prognosis and Metastasis of Gallbladder Cancer

Analysis of clinical significance of quantitative expression of VEGF mRNA and uPA mRNA in pancreatic cancer tissue

Both Urokinase-Type Plasminogen Activator (upa) and Its Receptor (upar) Relate to Stage and Prognosis of Gastric Carcinoma

Expression of uPA,uPAR,nm23-H1 in Human Colorectal Cancer and Its Relation to Tumor Invasion and Metastasis